Gene · 103611090
CDR1-AS: CDR1 antisense RNA
12 sourcesgene-search-2026-11-11-0.2.0
Cite this record
ConductScience Library. CDR1-AS: CDR1 antisense RNA. Genes, record 103611090. Release gene-search-2026-11-11-0.2.0, 11 Nov 2026. https://conductscience.org/library/genes/103611090
On this page
Gene
- Symbol
- CDR1-AS
- Name
- CDR1 antisense RNA
- NCBI Gene ID
- 103611090
- Aliases
- CDR1NAT, CDR1as, CIRS7, ciRS-7
- Type
- ncRNA
Source NCBI Gene
Proteins0
Reviewed human proteins whose Swiss-Prot entry states the gene.
None in this release.
Patents0
Patents whose sequence listing contains this protein's exact sequence. A patent can list a sequence without claiming it.
None in this release.
Drugs0
Drugs a ChEMBL mechanism record says act on the gene's protein, through Open Targets.
None in this release.
Trials0
Trials of those drugs. A trial joins the gene only through a drug that acts on it.
None in this release.
NIH grants247
NIH grants whose papers are about the gene, through NIH's grant-paper links.
| Grant | Title | CDR1-AS papers | Newest fiscal year |
|---|---|---|---|
| ZIAAG000511 | Post-transcriptional control of Proliferation, Stress Response & Carcinogenesis | 6 | 2025 |
| R35GM119735 | Regulatory roles for the Integrator complex and circular RNAs | 4 | 2025 |
| P50CA196530 | Yale SPORE in Lung Cancer (YSILC): The Biology and Personalized Treatment of Lung Cancer | 3 | 2025 |
| ZIAAG000393 | Influence of Post-transcriptional Gene Regulation on Cell Senescence and Aging | 3 | 2025 |
| P01HL134608 | Exosomes as mediators of cardiac injury and repair | 2 | 2025 |
| P20GM121288 | Center for Translational Viral Oncology (CTVO) | 2 | 2025 |
| P30CA016086 | Cancer Center Support Grant | 2 | 2025 |
| R01GM124406 | Unraveling regulatory functions of circRNAs at the muscleblind locus | 2 | 2025 |
| I01BX000332 | Posttranscriptional Control of Gut Mucosal Defense and Homeostasis | 1 | 2025 |
| IK6BX004213 | BLRD Research Career Scientist Award Application | 1 | 2025 |
1 to 10 of 247Source NIH's project files
See all 247 nih grantsPapers1,585
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Non-coding RNA in osteoarthritis: mechanistic insights and future perspectives. | Front Endocrinol (Lausanne) | 2026 | 42523837 | PubTator, text mining | PubMed |
| RETRACTION: Silencing CDR1as Enhances the Sensitivity of Breast Cancer Cells to Drug Resistance by Acting as a miR-7 Sponge to Down-Regulate REGγ. | J Cell Mol Med | 2026 | 42333945 | PubTator, text mining | PubMed |
| MicroRNA-7: a versatile player and core target in brain disorders. | J Transl Med | 2026 | 42204625 | PubTator, text mining | PubMed |
| The history and function of a circular RNA. | Nat Commun | 2026 | 42045181 | PubTator, text mining | PubMed |
| Diagnostic potential of circular RNAs in carotid atherosclerotic plaque vulnerability. | Noncoding RNA Res | 2026 | 41809636 | PubTator, text mining | PubMed |
| Circular RNAs: Key Regulators of Tumor Metabolic Reprogramming and Clinical Translation. | Oncol Res | 2026 | 41799520 | PubTator, text mining | PubMed |
| Blood-based epigenetic biomarkers in rheumatoid arthritis: current knowledge and future perspectives. | Front Immunol | 2026 | 41798917 | PubTator, text mining | PubMed |
| Assessing the contributions of noncoding RNAs in acute myeloid leukemia. | Blood Neoplasia | 2026 | 41798679 | PubTator, text mining | PubMed |
| Neuroimmune Interactions in Neurodegeneration: The Role of Microglia in Alzheimer's and Parkinson's Disease Pathogenesis. | Brain Sci | 2026 | 41750155 | PubTator, text mining | PubMed |
| The dual role of autophagy in cartilage degradation: from mechanisms to targeted therapeutics. | Front Cell Dev Biol | 2026 | 41716288 | PubTator, text mining | PubMed |
1 to 10 of 1,585
See all 1,585 papersSources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this gene from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/genes/v1/103611090
GET https://conductscience.org/api/genes/v1/103611090/grants?page=2